Startup profile · funding coverage
Komodo Health
Healthcare Map — real-world clinical data platform for life sciences and payers.
Stage
growth
Status
private
Coverage
full
Why Komodo Health is interesting
Komodo's longitudinal claims data powers pharma and payer analytics; Tiger and Coatue joined post-a16z-led Series C.
Key facts
- Series E (Mar 2021): $220M led by Tiger Global; a16z participated — Businesswire
- Series C (Jan 2020): $50M led by a16z; Oak HC/FT joined — Komodo press
- Healthcare Map — longitudinal real-world data for life sciences and payers
Investors in our directory
Funds linked from Komodo Health's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
FAQs about Komodo Health
Funding context and why this company shows up in venture coverage.
Komodo Health's Healthcare Map aggregates de-identified U.S. patient journey data for pharma, payers, and life-sciences analytics.
Andreessen Horowitz (see /fund/andreessen-horowitz) led the Series C; Tiger Global (/fund/tiger-global-management) led the Series E; Coatue (/fund/coatue) participated. Oak HC/FT joined the C but is not in our fund directory.
Komodo Health raised a $220M Series E in March 2021 led by Tiger Global, after a $50M Series C led by a16z in 2020.
Drug development and payer strategy depend on real-world evidence; Komodo's map is among the largest longitudinal healthcare datasets in the U.S.
Komodo Health remains private as of July 2026.
Last updated: 2026-07-24